)
)
Divi’s Laboratories Investor Relations Material
Latest events
Q3 24/25
Divi’s Laboratories
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Divi’s Laboratories Limited
Access all reports
DiviS Laboratories Ltd is engaged in the manufacture of Active Pharma Ingredients (APIs) and intermediates. The company offers bulk drug intermediates, APIs, and bulk drug intermediate blends for commercial and laboratory use. DiviS Laboratories' products are used for the synthesis of anti-cancer medicines, anti-infective agents and other pharmaceuticals.
Latest articles
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
)
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
DIVISLAB
Country
🇮🇳 India